High-Risk Drugs in Perfusion Applications: Molecular Mechanisms and Information Evaluation
Abstract
Aim: This study aimed to assess perfusionists’ knowledge of the molecular mechanisms and pharmacogenetic determinants of high-risk drugs. Materials and Methods: This descriptive, cross-sectional survey study was conducted among clinical perfusionists. The questionnaire included items measuring awareness of molecular pharmacology, genetic polymorphisms affecting drug response, and personalized treatment approaches in perfusion practice. Results: The majority of participants demonstrated moderate knowledge, with limited awareness specifically regarding molecular and pharmacogenetic mechanisms. Additionally, perfusionists who had received supplementary training exhibited significantly higher scores in the molecular and pharmacogenetic knowledge subdomain compared to those without such training (7.5±1.2 vs. 6.5±1.5; p < 0.001). Conclusion: Integrating the molecular mechanisms of high-risk drugs in perfusion applications into perfusion training and clinical practice can significantly improve drug safety, treatment efficacy and patient-specific management.
Keywords
Perfusionist, molecular mechanisms, high-risk drugs, cardiopulmonary bypass, personalized therapy.
References
- Buylaert WA, Herregods LL, Mortier EP, et al. Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. Clin Pharmacokinet. 1989;17(1):10-26. doi:10.2165/00003088- 198917010-00002.
- Holley FO, Ponganis KV, Stanski DR. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet. 1982;7(3):234-251. doi:10.2165/00003088-198207030-00004
- Miranda DM, Mamede M, Souza BR, et al. Molecular medicine: a path towards a personalized medicine. Braz J Psychiatry. 2012;34(1):82-91. doi:10.1016/s1516-4446(12)70015-6
- Tang H, Zhang Y, Wu Y, et al. The Emerging Era of Molecular Medicine. ACS Nano. 2024;18(45):30911-30918. doi:10.1021/ acsnano.4c07969
- Svyatova G, Berezina G, Murtazaliyeva A, et al. Genetic aspects of warfarin dosing algorithms in cardiac surgery patients who have undergone heart surgery: systematic review. Georgian Med News. 2025;(363):89-104
- Gorbunova EV, Rozhnev VV, Ponasenko AV, et al. Kardiologiia. 2019;59(9S):25-30. doi:10.18087/cardio.n681
- Elgart V, Lin JR, Loscalzo J. Determinants of drug-target interactions at the single cell level. PLoS Comput Biol. 2018;14(12):e1006601. doi:10.1371/journal.pcbi.1006601
- Gonçalves E, Segura-Cabrera A, Pacini C, et al. Drug mechanismof- action discovery through the integration of pharmacological and CRISPR screens. Mol Syst Biol. 2020;16(7):e9405. doi:10.15252/msb.20199405
- Tonge PJ. Drug-Target Kinetics in Drug Discovery. ACS Chem Neurosci. 2018;9(1):29-39. doi:10.1021/acschemneuro.7b00185
- Hogwood J, Mulloy B, Lever R, et al. Pharmacology of Heparin and Related Drugs: An Update. Pharmacol Rev. 2023;75(2):328- 379. doi:10.1124/pharmrev.122.000684